The United Kingdom just took a tremendous step forward in the cannabis movement. For the first time in the U.K., the coveted Charlotte’s Web strain will be offered in oil form by a London and Kent-based company called UK CBD.
Charlotte’s Web products are low in THC and high in CBD, made from varieties of hemp that are legal in the United Kingdom. UK CBD owner and CEO Nicholas P. Ellis released a statement on the products and the benefits to UK consumers:
“As leaders in the UK CBD market, we are extremely proud to partner with CW Botanicals and to legally add their exclusive Charlotte’s Web products to our already impressive range…We believe that introducing these products to the UK market will help many people suffering from ECS (endocannabinoid system) deficiencies or for those who just wish to add these nutritious cannabinoids to their daily dietary supplementation. Hemp is also rich in vitamins, minerals and omegas 3 & 6.”
Charlotte’s Web, as many are aware, is a high-CBD strain known for its anti-epileptic properties that reduced the number of seizures for little Charlotte Figi, the strain’s namesake. Before beginning treatment, Charlotte, affectionately known as Charlie, was suffering from up to 300 violent seizures a week. She suffered from a severe form of epilepsy, Dravet’s Syndrome, which is resistant to standard epilepsy medication. After discovering the strain and starting a standard dose of high-CBD cannabis oil, her seizures reduced down to two or three a week.
The United Kingdom has been making headway, with a recent petition calling for the legalization of cannabis in the UK that has attracted nearly 200,000 signatures. Any petitions with more than 100,000 signatures must be considered by Parliament, and this legalization petition is currently awaiting a debate date.
